Budget 2023: Healthcare industry expects tax incentives, policy support

The industry expects the Government to provide tax incentives for both new and existing healthcare projects, push for infrastructure development and simplified regulations.

Published: 18th January 2023 09:07 PM  |   Last Updated: 18th January 2023 09:07 PM   |  A+A-

healthcare, nursing

Image used for representational purpose only. (Illustration: Sourav Roy)

Express News Service

NEW DELHI: The healthcare and pharma industry has pinned big hopes on the upcoming Union Budget to be announced by Finance Minister Nirmala Sitharaman on February 1.

The industry expects the Government to provide tax incentives for both new and existing healthcare projects, push for infrastructure development and simplified regulations.

Dr Ashutosh Raghuvanshi, Senior Vice President, NATHEALTH and MD & CEO, Fortis Healthcare said, “India is amongst the most preferred destinations globally for medical tourism and therefore, increased policy support is required to encourage, and facilitate medical value travel to India, develop MVT as an organized sector. Another critical area is addressing the shortage of healthcare professionals – by identifying doctors, nurses and technical staff willing to work in Tier 2/3 cities and looking at non-traditional ways to double the number of doctors."

"…Further, the sector needs lower-cost financing through tax incentives for both existing and new healthcare projects. For new projects, the Government should provide a tax holiday period of 15 years and for existing projects, tax relief for 10 years as re-investment support. Declaring healthcare as a National Priority Sector and classifying it on the same lines as Agriculture (priority-sector lending), will give banks the flexibility to lend to private healthcare institutions, on longer tenures, at lower rates," Raghuvanshi said.

Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance said, "The budget should outline supportive policies, simplified regulations, and simple GST norms to aid in the development of the pharmaceutical industry. Measures to facilitate the ease of doing business will increase investment and contribute to the industry's long-term growth."

"Viability gap funding by the Government is essential to set up hospitals in tier-1 and tier-2 cities, encouraging increased investment in the healthcare infrastructure. Uniform adoption of the Ayushman Bharat Digital Mission is another imperative which calls for clearly defined delivery models for innovative modules developed by private players. We are also witnessing a significant impact on the cost of running a business which will affect the sustainability of MedTech organizations. If all payment backlogs both for providers and suppliers under insurance and public procurement are cleared, it would significantly improve the availability of healthcare infrastructure,” Dr Shravan Subramanyam, President, NATHEALTH said.  

Meanwhile, Pratik Kumar, Country Director, Malaria No More India said "India has set an ambitious goal of eliminating malaria from the country by 2030."

While achievable, this road to elimination still stands steep - the country accounted for 79% of the malaria burden in the South-East Asia Region, the highest in the region, as highlighted by WHO's World Malaria Report 2022.

“We hope that the Union Budget 2023-24 prioritizes allocating sufficient resources to Malaria, enabling our nation to achieve the momentous goal and bring us closer to a 'MalariaMuktBharat!',” Kumar said.


India Matters

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.